Z4. COVID-19 Treatment
Poster Session: COVID-19: Treatment
.jpeg.jpg "Essy Mozaffari, PharmD, MPH, MBA photo")
Essy Mozaffari, PharmD, MPH, MBA
Senior Director
Gilead Sciences
Foster, California, United States
Michele Bartoletti, MD, PhD
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Italy); IRCCS Humanitas Research Hospital, Rozzano (Italy)
Rozzano, Lombardia, Italy
Alpesh N. Amin, MD, MBA
University of California, Irvine
Orange, California, United States
Yohei Doi, MD, PhD
Fujita Health University
Aichi, Aichi, Japan
Paul LOUBET, MD, PhD (he/him/his)
Infectious Diseases Specialist
CHU de Nîmes
Nimes, Languedoc-Roussillon, France
Christina G. Rivera (O'Connor), Pharm.D
pharmacist
Mayo Clinic
Rochester, Minnesota, United States
Michael Roshon, MD/PhD, MD/PhD
VP of Quality and Clinical Operations
CommonSpirit Health, Mountain Region
Colorado Springs, Colorado, United States
Aaditya Rawal, MSc Law
Consultant
Costello Medical Inc.
Boston, Massachusetts, United States
Emily Kaiser, BS
Senior Analyst
Costello Medical
Boston, Massachusetts, United States
Maria Vutcovici Nicolae, MD MSc
Certara Canada
Montreal, Quebec, Canada
Olena Polyakova, MD, PhD
Certara
Montreal, Quebec, Canada
Thomas F. Oppelt, PharmD, BCPS
Sr. Director, Medical Affairs
Gilead Sciences, Inc
Foster City, California, United States
Mel Chiang, Ph.D.
Gilead Sciences
Taipei, Taipei, Taiwan
.jpg "Paul E. Sax, MD photo")
Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases; Professor of Medicine
Brigham and Women’s Hospital; Harvard Medical School
Boston, MA, United States
Andre Kalil, MD, MPH
Professor
University of Nebraska Medical Center, United States